Observed Signal · Aug 14, 2026 · earnings · Source: SEC API · Impact: 4.2/5

10-K Financial Filing Analysis for H&R Block (2026-08-14)

Executive Signal Summary

H&R Block, Inc. reported its consolidated financial results for the fiscal year ended June 30, 2026, delivering total revenues of $3.95 billion, representing a 4.9% increase year-over-year from $3.76 billion in fiscal 2025. Revenue growth was primarily driven by higher net average charges and volume growth in U.S. company-owned assisted tax preparation (up 6.1% to $2.56 billion), along with strong double-digit growth at Wave (up 12.3% to $122.7 million) and international operations (up 7.4% to $265.4 million). These gains were partially offset by a 3.9% decline in franchise royalty revenues resulting from strategic acquisitions of franchise locations into company-owned operations. Operating expenses grew 3.6% to $3.04 billion due to increased field compensation and technology infrastructure spending. Net income from continuing operations expanded 20.8% to $736.3 million, and diluted earnings per share reached $5.69, bolstered by operating leverage and a discrete income tax benefit of $84.1 million from the settlement of an IRS examination covering the 2020 tax year and related carryback claims. The company returned substantial capital to shareholders, executing $500.3 million in share repurchases and distributing $211.0 million in cash dividends, while maintaining robust liquidity with $958.7 million in unrestricted cash and an undrawn $1.5 billion revolving credit facility.

Polaris7 AgentPolaris7 Strategic Assessment
High Confidence

The filing demonstrates sustained pricing power and volume stability in assisted tax preparation, progressive expansion of high-margin small business SaaS solutions via Wave, and active capital return, counterbalancing persistent regulatory scrutiny and seasonality risks.

SIGNAL RADAR

Track H&R Block Signals & Market Shifts in Real-Time

Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.

Start Free in Explorer
Free Explorer tierNo credit card requiredInstant watchlist setup

Key Takeaways & Evidence Grounding

  • Fiscal 2026 consolidated revenue rose 4.9% year-over-year to $3.945 billion, with U.S. assisted tax preparation generating $2.561 billion and Wave contributing $122.7 million.
  • Net income from continuing operations reached $736.3 million ($5.69 diluted EPS), aided by an effective tax rate reduction to 13.8% following an $84.1 million discrete tax settlement benefit.
  • Capital allocation included $500.3 million spent to repurchase 10.5 million common shares and $211.0 million in dividends paid ($1.68 per share declared), with $600.0 million remaining under the buyback authorization.
Primary Source Grounding & Direct Attribution
Direct Origin Attribution
Primary Reporting: SEC API•Published: Aug 14, 2026

Related Market Signals & Shifts

Recent verified developments and strategic activity across this market segment.

financialsAug 5, 2026

10-Q Financial Filing Analysis for CVS Health (2026-08-05)

CVS Health Corporation reported strong financial results for the second quarter of 2026, driven by top-line growth across all major operating segments. Total revenues increased 7.3% year-over-year to $106.10 billion, up from $98.92 billion in Q2 2025. Operating income saw a substantial 97.5% increase to $4.70 billion, compared to $2.38 billion in the prior-year period, primarily supported by core operational improvements and the absence of $833 million in legacy litigation charges incurred in Q2 2025. Net income attributable to CVS Health rose significantly to $2.98 billion ($2.31 diluted EPS) from $1.02 billion ($0.80 diluted EPS). Performance in the Health Care Benefits segment reflected improved medical loss dynamics, with the Medical Benefit Ratio (MBR) declining to 87.4% from 89.9% in Q2 2025, driven by improved underlying Government business performance and the absence of prior-year premium deficiency reserves. Growth was supported by the Health Services segment, where revenues climbed 11.5% to $51.80 billion, and Pharmacy & Consumer Wellness, which posted a 2.9% increase in pharmacy same-store sales aided by Rite Aid file acquisitions. In regulatory matters, CVS reached a proposed settlement with the FTC to resolve outstanding PBM and pharmacy inquiries.

Read assessment
financialsJul 30, 2026

10-Q Financial Filing Analysis for Fortinet (2026-07-30)

Fortinet reported strong financial performance for the second quarter of fiscal 2026, with total revenue rising 26% year-over-year to $2.05 billion and operating income growing 51% to $689.3 million. Revenue expansion was driven by a 52% surge in product revenue to $773.0 million, fueled by higher hardware unit shipments, customer upgrades for AI-related infrastructure, and pricing actions, alongside a 14% increase in service revenue to $1.27 billion. Operating margin expanded by 5.6 percentage points to 33.7%, reflecting strong operating leverage as top-line growth outpaced operating expenses. Net income for the quarter reached $606.3 million ($0.82 per diluted share), up from $440.1 million in Q2 2025. Non-GAAP billings expanded 33% to $2.37 billion, and deferred revenue climbed to $7.68 billion, underscoring solid underlying demand across Secure Networking, Unified SASE, and SecOps platforms.

Read assessment
financialsAug 10, 2026

10-Q Financial Filing Analysis for NielsenIQ (2026-08-10)

NIQ Global Intelligence plc reported its financial results for the second quarter and six months ended June 30, 2026. For Q2 2026, consolidated revenue increased 8.0% year-over-year to $1,124.2 million, driven by solid demand across both Intelligence ($905.3 million) and Activation ($218.9 million) solutions and broad geographic growth across the Americas and EMEA. Operating income rose 65.7% to $65.3 million, supported by operating discipline and restructuring initiatives under the 2026 Program, while net loss narrowed to $(28.2) million compared to $(0.8) million in Q2 2025 primarily due to foreign exchange differences and income tax provisions. Interest expense decreased significantly from $95.2 million to $55.1 million following debt repayments funded by the July 2025 IPO proceeds and subsequent debt refinancings.

Read assessment
Executive Briefing & Watchlist

Receive all future signals for H&R Block & competitors in your briefing

Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.

Free Explorer tierNo credit cardUnsubscribe anytime